MSB 0.54% 92.5¢ mesoblast limited

WHO released the data from their mega Solidarity trial of 4...

  1. 92 Posts.
    lightbulb Created with Sketch. 93
    WHO released the data from their mega Solidarity trial of 4 potential Covid treatment options (including Remdesivir) which i have summarized below:

    • Study drugs were Remdesivir, Hydroxychloroquine, Lopinavir (fixed-dose combination with Ritonavir) and Interferon-β1a
    • COVID-19 patients were randomized equally between whichever study drugs were locally available and open control
    • 11,266 adults were randomized, with 2750 allocated Remdesivir, 954 Hydroxychloroquine, 1411 Lopinavir, 651 Interferon plus Lopinavir, 1412 only Interferon, and 4088 no study drug
    • Death rate ratios were: Remdesivir (301/2743 active vs 303/2708 control), Hydroxychloroquine (104/947 vs 84/906 control), Lopinavir (148/1399 vs 146/1372 control) and Interferon (243/2050 vs 216/2050 control)
    • Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay

    This study shows that there is currently no treatment that significantly reduces Covid-19 mortality. Note that the trial results do still need to be peer reviewed.

    https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1
    Last edited by davos97: 17/10/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
0.005(0.54%)
Mkt cap ! $1.056B
Open High Low Value Volume
93.0¢ 93.5¢ 91.5¢ $1.473M 1.596M

Buyers (Bids)

No. Vol. Price($)
1 32370 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 60258 5
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.